Evidence map›Paper›PMID 34811556›Full record

ReviewNature methods2022

Spatial mapping of protein composition and tissue organization: a primer for multiplexed antibody-based imaging.

John W Hickey, Elizabeth K Neumann, Andrea J Radtke, Jeannie M Camarillo, Rebecca T Beuschel, Alexandre Albanese, Elizabeth McDonough, Julia Hatler, Anne E Wiblin, Jeremy Fisher and 14 more

Abstract readReview
In one paragraph

Review in Nature methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 205 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
205citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

205 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Materials today. Bio · 2026
    Article
  18. Article
  19. Integrating Spatial Proteogenomics in Cancer Research.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  20. Article

145 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

John W Hickey *Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Elizabeth K Neumann *Department of Biochemistry, Vanderbilt University, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-6078-3321
Andrea J Radtke *Lymphocyte Biology Section and Center for Advanced Tissue Imaging, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA. andrea.radtke@nih.gov.ORCID http://orcid.org/0000-0003-4379-8967
Jeannie M CamarilloDepartments of Chemistry, Molecular Biosciences and the National Resource for Translational and Developmental Proteomics, Northwestern University, Evanston, IL, USA.
Rebecca T BeuschelLymphocyte Biology Section and Center for Advanced Tissue Imaging, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
Alexandre AlbaneseInstitute for Medical Engineering and Science, MIT, Cambridge, MA, USA.
Elizabeth McDonoughGE Research, Niskayuna, NY, USA.ORCID http://orcid.org/0000-0001-7524-8260
Julia HatlerAntibody Development Department, Bio-Techne, Minneapolis, MN, USA.
Anne E WiblinDepartment of Research and Development, Abcam, Cambridge, UK.
Jeremy FisherDepartment of Research and Development, Cell Signaling Technology, Danvers, MA, USA.
Josh CroteauDepartment of Applications Science, BioLegend, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-8142-0482
Eliza C SmallThermo Fisher Scientific, Rockford, IL, USA.
Anup SoodGE Research, Niskayuna, NY, USA.
Richard M CaprioliDepartment of Biochemistry, Vanderbilt University, Nashville, TN, USA.
R Michael AngeloDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-1531-5067
Garry P NolanDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-8862-9043
Kwanghun ChungInstitute for Medical Engineering and Science, MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-8167-3340
Stephen M HewittLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-8283-1788
Ronald N GermainLymphocyte Biology Section and Center for Advanced Tissue Imaging, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-1495-9143
Jeffrey M SpragginsMass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-9198-5498
Emma LundbergScience for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-7034-0850
Michael P SnyderDepartment of Genetics, Stanford University School of Medicine, Stanford, California, USA.ORCID http://orcid.org/0000-0003-0784-7987
Neil L KelleherDepartments of Chemistry, Molecular Biosciences and the National Resource for Translational and Developmental Proteomics, Northwestern University, Evanston, IL, USA.ORCID http://orcid.org/0000-0002-8815-3372
Sinem K SakaWyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA. sinem.saka@embl.de.ORCID http://orcid.org/0000-0002-5017-379X

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
Experimental Pathology Laboratory (EPL)ZICBC011638 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HEWITT, STEPHEN · 2015 to 2025
$16.6M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007028 · NIEHS · VANDERBILT UNIVERSITY · PI F PETER Guengerich, Fiona Edith Harrison · 1985 to 2026
$15.7M
Vanderbilt University Biomolecular Multimodal Imaging Center for 3-Dimensional Mapping of the Human KidneyU54DK134302 · NIDDK · VANDERBILT UNIVERSITY · PI SPRAGGINS, JEFFREY M · 2022 to 2025
$7.1M
Vanderbilt University Biomolecular Multimodal Imaging Center for 3-Dimensional Tissue MappingU54DK120058 · NIDDK · VANDERBILT UNIVERSITY · PI SPRAGGINS, JEFFREY M · 2018 to 2021
$5.7M
Pancreas Organ Specific ProjectU54EY032442 · NEI · VANDERBILT UNIVERSITY · PI POWERS, ALVIN C, SCHEY, KEVIN L · 2020 to 2024
$5.7M
Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometryR01AI138581 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric P Skaar, Jeffrey M Spraggins · 2018 to 2026
$5.2M
Stanford Tissue Mapping CenterU54HG010426 · NHGRI · STANFORD UNIVERSITY · PI PLEVRITIS, SYLVIA KATINA · 2018 to 2021
$5.1M
Defining the impact of host factors on the molecular architecture and bacterial physiology of Staphylococcus aureus abscessesR01AI145992 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CASSAT, JAMES E, SKAAR, ERIC P · 2020 to 2024
$3.8M
Multiscale, Multimodal Analysis of Skin and Spatial Cell OrganizationU54AR081775 · NIAMS · GENERAL ELECTRIC GLOBAL RESEARCH CTR · PI FALO, LOUIS D, GINTY, FIONA · 2022 to 2025
$2.6M
Multi-Scale 3-D Image Analytics for High Dimensional Spatial Mapping of Normal TissuesUH3CA246594 · NCI · GENERAL ELECTRIC GLOBAL RESEARCH CTR · PI GINTY, FIONA · 2019 to 2021
$2.1M
A robust platform for multiplexed, subcellular proteomic imaging in human tissueUH3CA246633 · NCI · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2019 to 2021
$1.8M
NCI NIH HHS T32 CA196585NCI NIH HHS UH3 CA246594NCI NIH HHS UH3 CA246633NCI NIH HHS UH3 CA246635NCI NIH HHS UH3 CA255133NEI NIH HHS U54 EY032442NHGRI NIH HHS U54 HG010426NHLBI NIH HHS UG3 HL145600NIAID NIH HHS R01 AI138581NIAID NIH HHS R01 AI145992NIAMS NIH HHS U54 AR081775NIDDK NIH HHS P30 DK020593NIDDK NIH HHS U54 DK120058NIDDK NIH HHS U54 DK134302NIEHS NIH HHS T32 ES007028
6 · The paper itself

Abstract

Tissues and organs are composed of distinct cell types that must operate in concert to perform physiological functions. Efforts to create high-dimensional biomarker catalogs of these cells have been largely based on single-cell sequencing approaches, which lack the spatial context required to understand critical cellular communication and correlated structural organization. To probe in situ biology with sufficient depth, several multiplexed protein imaging methods have been recently developed. Though these technologies differ in strategy and mode of immunolabeling and detection tags, they commonly utilize antibodies directed against protein biomarkers to provide detailed spatial and functional maps of complex tissues. As these promising antibody-based multiplexing approaches become more widely adopted, new frameworks and considerations are critical for training future users, generating molecular tools, validating antibody panels, and harmonizing datasets. In this Perspective, we provide essential resources, key considerations for obtaining robust and reproducible imaging data, and specialized knowledge from domain experts and technology developers.

Indexed as

AntibodiesCell CommunicationDiagnostic ImagingAntibodies

Identifiers

PMID34811556
PMCPMC9264278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.